Alzheimer's disease research, amyloid plaques, tau tangles, and cognitive decline
370 articoli
Individualized brain training targets specific cognitive weaknesses in adults over 50 with HIV-associated thinking problems.
Personalized treatment approach targeting multiple causes of cognitive decline outperformed standard care in 9-month trial.
60-patient trial explores whether metformin, combined with standard therapy, could slow Parkinson's progression through metabolic pathways.
Duke University study tests whether targeted brain stimulation can reverse age-related cognitive decline and improve working memory.
Health expert Max Lugavere shares his evidence-based approach to protecting brain health through lifestyle interventions.
Neurologist reveals evidence-based lifestyle habits that grow hippocampus size and reduce Alzheimer's risk by 50%.
Max Lugavere shares compassionate strategies for discussing cognitive decline with loved ones and neurologists while maintaining dignity.
Dr. Tommy Wood breaks down the science of preventing cognitive decline through his 3S framework for brain health.
Stanford researcher reveals how proteins in young blood can rejuvenate aging brains and improve cognition.
New research reveals how targeting the brain's glymphatic drainage system might remove harmful α-synuclein buildup in Parkinson's disease.
New review reveals how engineered peptides could revolutionize Alzheimer's therapy by targeting multiple disease pathways simultaneously.
New research reveals how GFAP protein actively shapes brain aging and could enable early detection of neurodegenerative diseases.
